Filed before 2025Filed 25 November 2014
N30 Pharmaceuticals, Inc. raised $30M
N30 Pharmaceuticals, Inc., a pharmaceuticals company based in Boulder, CO, raised $30M in a new equity round, according to a filing dated 25 November 2014.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 25 November 2014
- Round
- Equity round
- Amount sold
- $30M
- Offering size
- $40M
- Investors so far
- 12
- Based in
- Boulder, CO
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 89% of the 1,533 tracked raises with an amount filed in 2014, and than 85% of the 46 in pharmaceuticals.
Alpine Immune Sciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 29 Sep 2021 | New filing | $91M | Another raise |
| 7 Aug 2020 | New filing | $60M | Another raise |
| 30 Jan 2019 | New filing | $25.3M | Another raise |
| 25 Nov 2014 | New filing | $30M | This raise |
More with Marshall Ventures on the board
- Liberate Medical, Inc.$4.46M
- Useed, Inc.$300K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.